Cellular immune reactions of mice with alveolar echinococcosis after albendazole therapy

Helminthologia

Volumn 40, Issue 4, 2003, Pages 187-194

  Boroskova Z ^a   Dvoroznakova E ^a   Sevcikova Z ^a,b  

^a PARASITOLOGICAL INSTITUTE   (Slovakia)

^b UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

Author keywords

Albendazole; Alveolar echinococcosis; Cellular immunity; Mice

Indexed keywords

ANIMALIA; ECHINOCOCCUS; ECHINOCOCCUS MULTILOCULARIS;

EID: 1642364263     PISSN: 04406605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. AMMANN, R. W., ECKERT, J. (1996): Cestodes: Echinococcus. Gastroenter. Clin. North Am., 25: 655-689
2. AMMANN, R. W. (2000): Neo-und adjuvante therapie bei echinokokkose. Chirurg, 71: 9-15
3. BARON, E.W, TANNER, C. E. (1977): Echinococcus multilocularis in the mouse: the in vitro protoscolidical activity of peritoneal macrophages. Int. J. Parasitol., 7: 489-495
4. BOROŠKOVÁ, Z., DVOROŽŇÁKOVÁ, E., DUBINSKÝ, P., VELEBNÝ, S., TOMAŠOVIČOVÁ, O., MACHNICKA, B. (1998): Effect of free and liposomized albendazole on the immune responses in healthy and Toxocara canis-infected mice. Vet. Med. Czech, 43: 293-300
5. BRESSON-HADNI, S., LIANCE, A., MEYER, J. P., HOUIN, R., BRESSON, J. L., VUITTON, D. A. (1990): Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequental and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice. Clin. Exp. Immunol., 82: 378-383
6. CUSS, F. M. (2000): Interleukin 5. In NARULA, S. K., COFFMAN, R. (Eds): New Cytokines as Potential Drugs. Birkhäuser Verlag, Basel, Boston, Berlin: 1-14
7. DIXON, J. B., JENKINS, P. (1995): Immunology of mammalian metacestode infections. II. Immune recognition and effector function. Helminth. Abstr., 12: 599-613
8. DOENHOFF, M. J., LAMBERTUCCI, J. R., MCLAREN, D. J. (1991): The immune dependence of chemotherapy. Parasitol. Today, 7: 16-18
9. DVOROŽŇÁKOVÁ, E., BOROŠKOVÁ, Z., DUBINSKÝ, P., VELEBNÝ, S., TOMAŠOVIČOVÁ, O., MACHNICKA, B. (1998): Changes in cellular immunity of mice treated for larval toxocarosis with fenbendazole. Helminthologia, 35: 189-195
10. th Int. Cong. Hydatidology. Abstract book, Kusadasi, Turkey: 18
11. EMERY, I., LIANCE, M., DERIAUD, E., VUITTON, D. A., HOUIN, E., LECLERC, C. (1996): Characterization of T-cell immune responses of Echinococcus multilocularis-infected C57BL/6J mice. Parasite Immunol., 18: 463-472
12. EMERY, I., LECLERC, C., SENGPHOMMACHANH, K., VUITTON, D. A., LIANCE, M. (1998): In vivo treatment with recombinant IL-12 protects C57BL/6J mice against secondary alveolar echinococcosis. Parasite Immunol., 20: 81-91
13. GOTTSTEIN, B., WUNDERLIN, E., TANNER, I. (1994): Echinococcus multilocularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57BL/J) or "resistant" to secondary alveolar echinococcosis. Clin. Exp. Immunol., 96: 245-252
14. HRČKOVÁ, G., VELEBNY, S. (1997): Effect of praziquantel and liposome-incorporated praziquantel on peritoneal macrophage activation in mice infected with Mesocestoides corti tetrathyridia (Cestoda). Parasitology, 114: 475-482
15. JENNE, L., KILWINSKI, J., SCHEFFOD, W., KERN, P. (1997): IL-5 expressed by CD4+ lymphocytes from Echinococcus multilocularis-infected patients. Clin. Exp. Immunol., 109: 90-97
16. JENNE, L., KILWINSKI, J., RADLOFF, P., FLICK, W., KERN, P. (1998): Clinical efficacy of and immunologic alterations caused by interferon-therapy for alveolar echinococcis. Clin. Infect. Dis., 26: 492-494
17. KERN, P. (1997): Alveolar echinococcosis: management of patients with long standing and progressive alveolar echinococcosis. Arch. Inter. Hidatidosis, Lisboa, Portugal: 170-171
18. dull suppressor cells in spleens of mice intraperitoneally infected with E. multilocularis. J. Immunol., 147: 1659-1666
19. LIU, Y., WANG, X., GAO, J., YAO, Y., YU, D. (1998): Reevaluation of effect of albendazole on Echinococcus multilocularis infection in mice and gerbils. Chin. Med. J., 111: 917-924
20. LIANCE, M., RICARD-BLUM, S., EMERY, I., HOUIN, R., VUITTON, D. A. (1998): Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis. Parasite, 5: 231-237
21. OZERETSKOVSKAYA, N. N. (1980): Chemotherapy of parasitic diseases and immunodepression. Med. Parazit. Parazit. Bolez., 5: 3-12
22. OZERETKOVSKAYA, N. N. (1998): Approaches of the Russian school of immunological parasitologists to therapy of parasitic diseases. Med. Parazit. Parazit. Bolez., 2: 8-11
23. PAGÉ, M., BEJAOUNI, N., CIQO-MARS, B., LEMIEUX, P. (1988): Optimization of the terazolium based colorimetric assay for the measurement of cell number and cytotoxicity. Int. J. Immunopharmacol., 10: 785-793
24. PAWLOWSKI, Z. S., ECKERT, J., VUITTON, D. A., AMMANN, R. W., KERN, P., CRAIG, P. S., DAR, K. F., ROSA, DE F., FILICE, C., GOTTSTEIN, B., GRIMM, F., MACPHERSON, C. N. L., SATO, N., TODOROV, T., UCHINO, J., SINNER, VON W., WEN, H. (2001): Echinococcosis in humans: clinical aspects, diagnosis and treatment. In ECKERT, J., GEMMEL, M. A., MESLIN, F. X. PAWLOWSKI, Z. S. (Eds): WHO/OIE Manual on Echinococcosis in Humans and Animals: a Public Health Problem of Global Concern. World Organisation for Animal Health. Paris, France: 20-71
25. RAU, M. E., TANNER, C. E. (1975): BCG suppresses growth and metastasis of hydatid infections. Nature, 256: 318-319
26. RESCH, K. (1999): Cytokines. In NIJKAMP F. P., PARNHAM, M. J. (Eds): Principles of Immunopharmacology. Birghäuser Verlag, Basel, Boston, Berlin: 53-81
27. REUBEN, J. M, TANNER, C. E. (1983): Protection against experimental echinococcosis by non-specifically stimulated peritoneal cells. Parasite Immunol., 5: 61-66
28. SIRACUSANO, A., TEGGI, A., RIGANO, R., ORTONA, E., IOPOLO, S., NOTARGIACOMO, S., ROSA, F. D. E., VICARI, G. (1992): Cellular immune response in patients with hydatid disease before and after pharmacological treatment with benzimidazole carbamates Mediter. J. Infect. Parasit. Dis., 7: 263-266
29. SCHMID, M., SAMONNIG, H., STOGER, H., AUER, H., STERNTHAL, M. H., WILDERS-TRUSCHNIG, M. (1995): Use of interferon gamma and mebendazole to stop the progression of alveolar hydatid disease: case report. Clin. Infect. Dis., 20: 1543-1546
30. STOBO, J. D. (1980): Mitogens. Clin. Immunol., 4: 55-72
31. STURM, D., MENZEL, J., GOTTSTEIN, B., KERN, P. (1995): Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect. Immun., 63: 1688-1697
32. SCHANTZ, P. M. (2002): Progress and challenges in biology, treatment and control of echinococcosis. Abstracts ICOPA X, Vancouver, Canada: 243
33. STETTLER, M., SILES-LUCAS, M., SARCIRON, E., LAWTON, P., GOTTSTEIN, B., HEMPHILL, A. (2001): Echinococcus multilocularis alkaline phosphatase as a marker for Metacestode domage induced by in vitro drug treatment with albendazole sulfoxide and albendazole sulfone. Antimicrob. Agents. Chemotherapy, 45: 2256-2262
34. ŠOLTÝS, J., QUINN, M. T. (1999a): Modulation of endotoxin-and enterotoxin-induced cytokine release by in vivo treatment with β-(1,6)-branched β-(1,3)-glucan. Infect. Immun., 67: 244-252
35. ŠOLTÝS, J., TURČEKOVÁ, L'., RYCKE, DE P. H. (1999b): The effect Echinococcus hydatid cyst fluid and protoscoleces on mouse peritoneal macrophages and spleen lymphocytes. Helminthologia, 36: 25-30
36. VUITTON, D. A., LIANCE, M., GODOT, V., EMERY, I., PATER, C., LECLERC, C., SARCIRON, M. E., PETAVY, A. F., BRESON-HADNI, S. (1997). Experimental models and clinical studies with interferons, cytokines and other immunostimulants. Arch. Inter. Hidatidosis. Lisboa, Portugal: 173-176
37. VUITTON, D. A., GODOT, V., HARRAGA, S., LIANCE, M., BEURTON, I., BRESSON-HADNI, S. (2001): Echinococcoses: a parasitic model for understanting allergic diseases? Rev. Fr. Allergol. Immunol. Clin., 41: 285-293
38. VUITTON, D. A. (2003): The ambiguous role of immunity in Echinococcosis: protection of the host or of the parasite? Acta Trop., 85: 119-132
39. WEN, H., NEW, R. R. C., MUHMUT, M., WANG, J. H., WANG, Y. H., ZHANG, J. H., SHAO, Y. M., CRAIG, P. S. (1996): Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine. Parasitology, 113: 111-121
40. WILSON, J. F., RAUSCH, R. L., MCMAHON, B. J., SCHANTZ, P. M. (1992): Parasiticidal effect of chemotherapy in alveolar hydatid disease: rewiev of experience with mebendazole and albendazole in Alaskan Eskimos. Clin. Infect. Dis., 15: 234-249